ProfileGDS4095 / 226577_at
TitleTamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OrganismHomo sapiens


SRC1 knockdown control tamoxifen untreated tamoxifen untreated GSM709767 GSM709769 GSM709765 GSM709771 GSM709772 GSM709775 GSM709764 GSM709766 GSM709768 GSM709777 GSM709770 GSM709773 GSM709774 GSM709776 74% 76% 75% 75% 75% 75% 75% 75% 76% 76% 75% 75% 75% 75% sort by genotype/variation sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM709767LY2 SRC1-siRNA tamoxifen treated rep17.6999974
GSM709769LY2 SRC1-siRNA tamoxifen treated rep38.0422976
GSM709765LY2 SRC1-siRNA untreated rep37.7308375
GSM709771LY2 SRC1-siRNA untreated rep17.8617175
GSM709772LY2 SRC1-siRNA untreated rep27.809375
GSM709775LY2 SRC1-siRNA untreated rep47.7726875
GSM709764LY2 control-siRNA tamoxifen treated rep27.8835475
GSM709766LY2 control-siRNA tamoxifen treated rep37.8156475
GSM709768LY2 control-siRNA tamoxifen treated rep17.96876
GSM709777LY2 control-siRNA tamoxifen treated rep48.0340476
GSM709770LY2 control-siRNA untreated rep37.9218175
GSM709773LY2 control-siRNA untreated rep17.8142475
GSM709774LY2 control-siRNA untreated rep27.8489575
GSM709776LY2 control-siRNA untreated rep47.7442875